These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23560247)

  • 21. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.
    Wu XS
    Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anhydrous reverse micelle lecithin nanoparticles/PLGA composite microspheres for long-term protein delivery with reduced initial burst.
    Chen L; Mei L; Feng D; Huang D; Tong X; Pan X; Zhu C; Wu C
    Colloids Surf B Biointerfaces; 2018 Mar; 163():146-154. PubMed ID: 29291500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Toxicity of Intravitreally Injected PLGA Microspheres and Rods in Monkeys and Rabbits: Effects of Depot Size on Inflammatory Response.
    Thackaberry EA; Farman C; Zhong F; Lorget F; Staflin K; Cercillieux A; Miller PE; Schuetz C; Chang D; Famili A; Daugherty AL; Rajagopal K; Bantseev V
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4274-4285. PubMed ID: 28850638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Cell Behavior and Antibiotic Activity under Sustained Release of Doxycycline-Loaded Poly(lactic-co-glycolic acid) Microspheres.
    Pedrini F; Nazato VS; Hausen MA; Komatsu D; Peña SS; Almeida ALM; Pirola FJC; Françoso MP; Duek EAR
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
    Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
    J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system.
    Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH
    J Microencapsul; 2000; 17(3):343-62. PubMed ID: 10819422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
    Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.
    Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J
    Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir.
    Alkholief M; Albasit H; Alhowyan A; Alshehri S; Raish M; Abul Kalam M; Alshamsan A
    Saudi Pharm J; 2019 Feb; 27(2):293-302. PubMed ID: 30766442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulation and release of doxycycline from electrospray-generated PLGA microspheres: Effect of polymer end groups.
    Wang J; Helder L; Shao J; Jansen JA; Yang M; Yang F
    Int J Pharm; 2019 Jun; 564():1-9. PubMed ID: 30978487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microspheres prepared with different co-polymers of poly(lactic-glycolic acid) (PLGA) or with chitosan cause distinct effects on macrophages.
    Bitencourt Cda S; Silva LB; Pereira PA; Gelfuso GM; Faccioli LH
    Colloids Surf B Biointerfaces; 2015 Dec; 136():678-86. PubMed ID: 26497115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable PLGA microcarriers for injectable delivery of chondrocytes: effect of surface modification on cell attachment and function.
    Chun KW; Yoo HS; Yoon JJ; Park TG
    Biotechnol Prog; 2004; 20(6):1797-801. PubMed ID: 15575714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimising poly(lactic-co-glycolic acid) microparticle fabrication using a Taguchi orthogonal array design-of-experiment approach.
    Mensah RA; Kirton SB; Cook MT; Styliari ID; Hutter V; Chau DYS
    PLoS One; 2019; 14(9):e0222858. PubMed ID: 31557205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.